A new study conducted in the U.S. Food and Drug Administration’s (FDA) laboratory reveals radically high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.

Tests conducted at the FDA’s White Oak Campus in Maryland showed residual DNA levels exceeded regulatory safety limits by 6 to 470 times.

The peer-reviewed study was undertaken by three student researchers under the supervision of FDA scientists. It was published in the Journal of High School Science on December 29, 2024.